More Speculation About GLP-1s, Consumers, and Economics
January 2, 2025 — Will savings from reduced food and beverage spending be sufficient to cover the cost of obesity medicines? Will these medicines transform the patterns of a whole range of consumer purchases? Speculation about GLP-1s, consumers, and economics is rampant right now. It’s popping up in both serious economic reporting and academic journals. The speculation is only […]
